US EditionKennedy’s vaccine panel votes to delay hepatitis B vote
The CDC vaccine advisory committee postponed a vote on delaying newborn hepatitis B shots and voted 8-3 to restrict the combined MMRV vaccine for children under four, citing seizure risks.
- The Advisory Committee on Immunization Practices voted to delay discussing the recommendation for universal hepatitis B vaccination at birth, a policy established over 30 years ago.
- Experts from the CDC emphasized the importance of universal birth vaccination due to screening gaps, stating that about 12% to 16% of women in the U.S. do not receive hepatitis B testing.
- Data presented by the CDC highlighted that universal birth vaccination acts as a safety net for U.S. children, despite testing gaps in mothers.
- The ACIP has not set a timetable for revisiting the hepatitis B vaccine vote, with their next meeting scheduled for October 22 and 23.
68 Articles
68 Articles
Mercury in Your Hot Dog? Vaccine Skeptics Face Their Limits at Crucial CDC Meeting
ATLANTA — Public health officials watched with dread as a panel shaped by the Trump administration took up an agenda to begin dismantling six decades of vaccination development and progress. But while the result seemed foretold, the debate was far from unanimous. The Advisory Committee on Immunization Practices, or ACIP, met at a satellite campus of the Centers for Disease Control and Prevention because the agency’s headquarters were still smash…
CDC vaccine advisers delay controversial vote on hepatitis B vaccine
(The Hill) - Key vaccine advisors to the Centers for Disease Control and Prevention voted 11-1 Friday morning to delay a recommendation on changes to a newborn hepatitis B vaccine, a surprise development that was greeted with relief by infectious disease experts. The vote came after a lengthy and tense discussion on Thursday about the necessity of giving newborn babies the vaccine, rather than waiting until they are at least a month old. Memb…
RFK Jr.'s vaccine advisers change guidance around COVID shots, MMRV vaccines for young kids
The Friday vote takes a step back on recommending the COVID-19 shot — rather than recommending it outright for most adults as they have in the past, the panel voted that the vaccine should be available to everyone, and folks should make a personal decision about whether or not to get it alongside their doctor.
CDC’s Vaccine Panel Postpones a MAHA-Backed Hepatitis B Vaccine Vote
Health Secretary Robert F. Kennedy Jr.'s hand-picked vaccine panel is leaving its vote on whether to stop recommending the Hepatitis B vaccine for newborns for another day.The Advisory Committee on Immunization Practices on Friday opted to indefinitely table its scheduled vote on whether newborns should continue to receive the Hepatitis B vaccine immediately after birth, with its members saying they felt unready to make the decision.“We are more…
In an unorthodox move, CDC vaccine advisers table a vote on hepatitis B
The Centers for Disease Control and Prevention is not expected to change recommendations for hepatitis B vaccines in newborns, after its panel of advisers tabled Friday a much-awaited vote on the issue.
Coverage Details
Bias Distribution
- 47% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
